BFEC
VCYT icon

Benjamin F. Edwards & Company’s Veracyte VCYT Stock Holding History

Benjamin F. Edwards & Company’s Portfolio VCYT Stock Details VCYT Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2024
Q2 		$634K Buy
29,248
+28,747
+5,738% +$604K 0.01% 636
2024
Q1 		$11K Buy
+501
New +$12.2K ﹤0.01% 1687
2022
Q3 		– Sell
-375
Closed -$7K – 1916
2022
Q2 		$7K Buy
+375
New +$7.58K ﹤0.01% 1479
2017
Q4 		– Sell
-270
Closed -$2K – 1629
2017
Q3 		$2K Hold
270
– – ﹤0.01% 1461
2017
Q2 		$2K Buy
+270
New +$2.2K ﹤0.01% 1395

Other funds holding VCYT

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $580B AUM 38.23% 1-Year Est. Return
AIM
ARK Investment Management St. Petersburg, Florida $15.4B AUM 50.29% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $552B AUM 44.19% 1-Year Est. Return
Sumitomo Mitsui Trust Group
Sumitomo Mitsui Trust Group Minato-Ku, Tokyo, Japan $175B AUM 40.63% 1-Year Est. Return
NAMA
Nikko Asset Management Americas New York $7.75B AUM 33.73% 1-Year Est. Return
CIP
Champlain Investment Partners Burlington, Vermont $3.89B AUM 16.15% 1-Year Est. Return
Artisan Partners
Artisan Partners Milwaukee, Wisconsin $63.1B AUM 35.51% 1-Year Est. Return
ACH
ArrowMark Colorado Holdings Denver, Colorado $2.4B AUM 42.85% 1-Year Est. Return

Benjamin F. Edwards & Company's VCYT Position: Q2 2024 in Review

Benjamin F. Edwards & Company increased its Veracyte (VCYT) stake by 5,738% in Q2 2024, buying an estimated $604K and bringing the position to 29,248 shares worth $634K. The position accounts for 0.01% of the portfolio, ranked #636.

Benjamin F. Edwards & Company first reported a position in VCYT in Q2 2017 and has held it in 5 quarters since. 240 funds tracked by Wall St. Rank hold VCYT as of Q2 2024.

  • Benjamin F. Edwards & Company held 29,248 shares of Veracyte worth $634K as of Q2 2024.
  • Benjamin F. Edwards & Company bought 28,747 Veracyte shares in Q2 2024, an estimated $604K.
  • Veracyte made up 0.01% of Benjamin F. Edwards & Company's portfolio in Q2 2024, its #636 holding.
  • Benjamin F. Edwards & Company first reported a position in Veracyte in Q2 2017 and has held it in 5 quarters since.
  • 240 funds tracked by Wall St. Rank held Veracyte as of Q2 2024.

Based on Benjamin F. Edwards & Company's 13F filing for Q2 2024, filed 12 Aug 2024.